Global Antibody-drug Conjugates Market Growth 2021-2026
According to this latest study, the 2021 growth of Antibody-drug Conjugates will have significant change from previous year. By the most conservative estimates of global Antibody-drug Conjugates market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2674.9 million in 2020. Over the next five years the Antibody-drug Conjugates market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 3236 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugates market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Adcetris
Kadcyla
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Breast Cancer
Lymphoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
ImmunoGen
Seattle Genetics
Roche
Takeda
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody-drug Conjugates Consumption 2016-2026
2.1.2 Antibody-drug Conjugates Consumption CAGR by Region
2.2 Antibody-drug Conjugates Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyla
2.3 Antibody-drug Conjugates Sales by Type
2.3.1 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2016-2021)
2.3.3 Global Antibody-drug Conjugates Sale Price by Type (2016-2021)
2.4 Antibody-drug Conjugates Segment by Application
2.4.1 Breast Cancer
2.4.2 Lymphoma
2.5 Antibody-drug Conjugates Sales by Application
2.5.1 Global Antibody-drug Conjugates Sale Market Share by Application (2016-2021)
2.5.2 Global Antibody-drug Conjugates Revenue and Market Share by Application (2016-2021)
2.5.3 Global Antibody-drug Conjugates Sale Price by Application (2016-2021)
3 Global Antibody-drug Conjugates by Company
3.1 Global Antibody-drug Conjugates Sales Market Share by Company
3.1.1 Global Antibody-drug Conjugates Sales by Company (2019-2021)
3.1.2 Global Antibody-drug Conjugates Sales Market Share by Company (2019-2021)
3.2 Global Antibody-drug Conjugates Revenue Market Share by Company
3.2.1 Global Antibody-drug Conjugates Revenue by Company (2019-2021)
3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Company (2019-2021)
3.3 Global Antibody-drug Conjugates Sale Price by Company
3.4 Global Manufacturers Antibody-drug Conjugates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody-drug Conjugates Product Location Distribution
3.4.2 Players Antibody-drug Conjugates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Antibody-drug Conjugates by Region
4.1 Global Antibody-drug Conjugates by Region
4.1.1 Global Antibody-drug Conjugates Sales by Region
4.1.2 Global Antibody-drug Conjugates Revenue by Region
4.2 Americas Antibody-drug Conjugates Sales Growth
4.3 APAC Antibody-drug Conjugates Sales Growth
4.4 Europe Antibody-drug Conjugates Sales Growth
4.5 Middle East & Africa Antibody-drug Conjugates Sales Growth
5 Americas
5.1 Americas Antibody-drug Conjugates Sales by Country
5.1.1 Americas Antibody-drug Conjugates Sales by Country (2016-2021)
5.1.2 Americas Antibody-drug Conjugates Revenue by Country (2016-2021)
5.2 Americas Antibody-drug Conjugates Sales by Type
5.3 Americas Antibody-drug Conjugates Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody-drug Conjugates Sales by Region
6.1.1 APAC Antibody-drug Conjugates Sales by Region (2016-2021)
6.1.2 APAC Antibody-drug Conjugates Revenue by Region (2016-2021)
6.2 APAC Antibody-drug Conjugates Sales by Type
6.3 APAC Antibody-drug Conjugates Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody-drug Conjugates by Country
7.1.1 Europe Antibody-drug Conjugates Sales by Country (2016-2021)
7.1.2 Europe Antibody-drug Conjugates Revenue by Country (2016-2021)
7.2 Europe Antibody-drug Conjugates Sales by Type
7.3 Europe Antibody-drug Conjugates Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody-drug Conjugates by Country
8.1.1 Middle East & Africa Antibody-drug Conjugates Sales by Country (2016-2021)
8.1.2 Middle East & Africa Antibody-drug Conjugates Revenue by Country (2016-2021)
8.2 Middle East & Africa Antibody-drug Conjugates Sales by Type
8.3 Middle East & Africa Antibody-drug Conjugates Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antibody-drug Conjugates Distributors
10.3 Antibody-drug Conjugates Customer
11 Global Antibody-drug Conjugates Market Forecast
11.1 Global Antibody-drug Conjugates Forecast by Region
11.1.1 Global Antibody-drug Conjugates Forecast by Regions (2021-2026)
11.2.2 Global Antibody-drug Conjugates Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Antibody-drug Conjugates Forecast by Type
11.7 Global Antibody-drug Conjugates Forecast by Application
12 Key Players Analysis
12.1 ImmunoGen
12.1.1 ImmunoGen Company Information
12.1.2 ImmunoGen Antibody-drug Conjugates Product Offered
12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 ImmunoGen Main Business Overview
12.1.5 ImmunoGen Latest Developments
12.2 Seattle Genetics
12.2.1 Seattle Genetics Company Information
12.2.2 Seattle Genetics Antibody-drug Conjugates Product Offered
12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Seattle Genetics Main Business Overview
12.2.5 Seattle Genetics Latest Developments
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Antibody-drug Conjugates Product Offered
12.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Roche Main Business Overview
12.3.5 Roche Latest Developments
12.4 Takeda
12.4.1 Takeda Company Information
12.4.2 Takeda Antibody-drug Conjugates Product Offered
12.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Takeda Main Business Overview
12.4.5 Takeda Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Antibody-drug Conjugates Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Adcetris
Table 3. Major Players of Kadcyla
Table 4. Global Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 5. Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 6. Global Antibody-drug Conjugates Revenue by Type (2016-2021) & ($ million)
Table 7. Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021)
Table 8. Global Antibody-drug Conjugates Sale Price by Type (2016-2021)
Table 9. Global Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 10. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 11. Global Antibody-drug Conjugates Value by Application (2016-2021)
Table 12. Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2021)
Table 13. Global Antibody-drug Conjugates Sale Price by Application (2016-2021)
Table 14. Global Antibody-drug Conjugates Sales by Company (2019-2021) & (Kg)
Table 15. Global Antibody-drug Conjugates Sales Market Share by Company (2019-2021)
Table 16. Global Antibody-drug Conjugates Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Antibody-drug Conjugates Revenue Market Share by Company (2019-2021)
Table 18. Global Antibody-drug Conjugates Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Antibody-drug Conjugates Producing Area Distribution and Sales Area
Table 20. Players Antibody-drug Conjugates Products Offered
Table 21. Antibody-drug Conjugates Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Antibody-drug Conjugates Sales by Region (2016-2021) (Kg)
Table 25. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
Table 26. Global Antibody-drug Conjugates Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)
Table 28. Americas Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 29. Americas Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
Table 30. Americas Antibody-drug Conjugates Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
Table 32. Americas Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 33. Americas Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 34. Americas Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 35. Americas Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 36. APAC Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)
Table 37. APAC Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
Table 38. APAC Antibody-drug Conjugates Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)
Table 40. APAC Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 41. APAC Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 42. APAC Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 43. APAC Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 44. Europe Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 45. Europe Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
Table 46. Europe Antibody-drug Conjugates Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
Table 48. Europe Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 49. Europe Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 50. Europe Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 51. Europe Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 53. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Antibody-drug Conjugates Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 57. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 59. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Antibody-drug Conjugates
Table 61. Key Application and Potential Industries of Antibody-drug Conjugates
Table 62. Key Challenges of Antibody-drug Conjugates
Table 63. Key Trends of Antibody-drug Conjugates
Table 64. Antibody-drug Conjugates Distributors List
Table 65. Antibody-drug Conjugates Customer List
Table 66. Global Antibody-drug Conjugates Sales Forecast by Region (2021-2026) & (Kg)
Table 67. Global Antibody-drug Conjugates Consumption Market Forecast by Region
Table 68. Global Antibody-drug Conjugates Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Antibody-drug Conjugates Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Antibody-drug Conjugates Sales Forecast by Country (2021-2026) & (Kg)
Table 71. Americas Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Antibody-drug Conjugates Sales Forecast by Region (2021-2026) & (Kg)
Table 73. APAC Antibody-drug Conjugates Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Antibody-drug Conjugates Sales Forecast by Country (2021-2026) & (Kg)
Table 75. Europe Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Antibody-drug Conjugates Sales Forecast by Country (2021-2026) & (Kg)
Table 77. Middle East & Africa Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Antibody-drug Conjugates Sales Forecast by Type (2021-2026) & (Kg)
Table 79. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Antibody-drug Conjugates Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Antibody-drug Conjugates Sales Forecast by Application (2021-2026) & (Kg)
Table 83. Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Antibody-drug Conjugates Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Antibody-drug Conjugates Revenue Market Share Forecast by Application (2021-2026)
Table 86. ImmunoGen Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 87. ImmunoGen Antibody-drug Conjugates Product Offered
Table 88. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 89. ImmunoGen Main Business
Table 90. ImmunoGen Latest Developments
Table 91. Seattle Genetics Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 92. Seattle Genetics Antibody-drug Conjugates Product Offered
Table 93. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 94. Seattle Genetics Main Business
Table 95. Seattle Genetics Latest Developments
Table 96. Roche Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Antibody-drug Conjugates Product Offered
Table 98. Roche Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. Takeda Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 102. Takeda Antibody-drug Conjugates Product Offered
Table 103. Takeda Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 104. Takeda Main Business
Table 105. Takeda Latest Developments
List of Figures
Figure 1. Picture of Antibody-drug Conjugates
Figure 2. Antibody-drug Conjugates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody-drug Conjugates Sales Growth Rate 2016-2026 (Kg)
Figure 7. Global Antibody-drug Conjugates Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Antibody-drug Conjugates Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Adcetris
Figure 10. Product Picture of Kadcyla
Figure 11. Global Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021)
Figure 13. Antibody-drug Conjugates Consumed in Breast Cancer
Figure 14. Global Antibody-drug Conjugates Market: Breast Cancer (2016-2021) & (Kg)
Figure 15. Antibody-drug Conjugates Consumed in Lymphoma
Figure 16. Global Antibody-drug Conjugates Market: Lymphoma (2016-2021) & (Kg)
Figure 17. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Figure 18. Global Antibody-drug Conjugates Revenue Market Share by Application in 2020
Figure 19. Antibody-drug Conjugates Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Antibody-drug Conjugates Revenue Market Share by Company in 2020
Figure 21. Global Antibody-drug Conjugates Sales Market Share by Regions (2016-2021)
Figure 22. Global Antibody-drug Conjugates Revenue Market Share by Region in 2020
Figure 23. Americas Antibody-drug Conjugates Sales 2016-2021 (Kg)
Figure 24. Americas Antibody-drug Conjugates Revenue 2016-2021 ($ Millions)
Figure 25. APAC Antibody-drug Conjugates Sales 2016-2021 (Kg)
Figure 26. APAC Antibody-drug Conjugates Revenue 2016-2021 ($ Millions)
Figure 27. Europe Antibody-drug Conjugates Sales 2016-2021 (Kg)
Figure 28. Europe Antibody-drug Conjugates Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Antibody-drug Conjugates Sales 2016-2021 (Kg)
Figure 30. Middle East & Africa Antibody-drug Conjugates Revenue 2016-2021 ($ Millions)
Figure 31. Americas Antibody-drug Conjugates Sales Market Share by Country in 2020
Figure 32. Americas Antibody-drug Conjugates Revenue Market Share by Country in 2020
Figure 33. Americas Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 34. Americas Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 35. United States Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Antibody-drug Conjugates Sales Market Share by Region in 2020
Figure 40. APAC Antibody-drug Conjugates Revenue Market Share by Regions in 2020
Figure 41. APAC Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 42. APAC Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 43. China Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Antibody-drug Conjugates Sales Market Share by Country in 2020
Figure 50. Europe Antibody-drug Conjugates Revenue Market Share by Country in 2020
Figure 51. Europe Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 52. Europe Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 53. Germany Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 62. Egypt Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
